{"product_id":"scripps-cardiovascular-atherosclerosis-prediction-prevention-and-management-2023","title":"Scripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2023","description":"\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eScripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2023 Despite notable advances in management, atherosclerotic cardiovascular disease (ASCVD) and its major clinical manifestations remains a leading cause of both morbidity and mortality worldwide. In the United States alone, ASCVD is the leading cause of death in most racial and ethnic populations and is estimated to cost more than $200 billion per year due to medications, healthcare service utilization, and productivity losses.\u003cbr\u003e\u003cbr\u003eMany of these human and economic costs are largely attributable to poor implementation of prevention strategies in adults and failure to control ASCVD risk factors using available medications and lifestyle interventions. The Scripps Cardiovascular Atherosclerosis conference is designed to assist clinicians in the prevention, diagnosis, treatment, and ongoing management of ASCVD among patients in their clinical practices as well as to promote increased awareness of prudent lifestyle and dietary choices to improve patient outcomes.\u003cbr\u003e\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cstrong\u003e+ Include: 13 videos + 1 pdf, size: 2.36 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: cardiologist, endocrinologists, internists\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAfter attending this live activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDiscuss the principles and applications of personalized medicine and genomics in the management of atherosclerotic cardiovascular disease.\u003c\/li\u003e\n\u003cli\u003eDescribe the latest advances in the management of hypertension and its impact on atherosclerotic cardiovascular disease.\u003c\/li\u003e\n\u003cli\u003eAssess the role of glucagon-like peptide-1 (GLP-1) agonists in the pharmacotherapy of obesity and type 2 diabetes.\u003c\/li\u003e\n\u003cli\u003eEvaluate the role of high-sensitivity troponin in risk assessment, including its use in combination with other clinical and laboratory assessments.\u003c\/li\u003e\n\u003cli\u003eExplain the role of health care providers in the implementation  and interpretation of genetic testing results for familial hypercholesterolemia.\u003c\/li\u003e\n\u003cli\u003eApply the latest guidelines for the diagnosis and treatment of dyslipidemia, including the use of lipid-lowering therapy.\u003c\/li\u003e\n\u003cli\u003eAssess the impact of new and emerging lipid-lowering agents on patient outcomes.\u003c\/li\u003e\n\u003cli\u003eCite the latest guidelines and evidence-based recommendations for the selection of therapies for individual patients with heart failure.\u003c\/li\u003e\n\u003cli\u003eDetermine the potential role of supplements in the primary and secondary prevention of atherosclerotic cardiovascular disease.\u003c\/li\u003e\n\u003cli\u003eDescribe current principles and applications of non-invasive coronary evaluations, including computed tomography (CT) coronary artery imaging.\u003c\/li\u003e\n\u003cli\u003eSummarize the latest information regarding nonalcoholic fatty liver disease, including epidemiology, pathophysiology and contribution to cardiovascular disease.\u003c\/li\u003e\n\u003cli\u003eAnalyze data regarding the effects of testosterone on the cardiovascular system and the risk of cardiovascular disease in men receiving testosterone therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiologists\u003c\/li\u003e\n\u003cli\u003eEndocrinologists\u003c\/li\u003e\n\u003cli\u003eInternists\u003c\/li\u003e\n\u003cli\u003eGeneral Practitioners\u003c\/li\u003e\n\u003cli\u003eNurses, Nurse Practitioners, Physician Assistants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ebrochure_lipids23_compressed.pdf\u003c\/li\u003e\n\u003cli\u003eAdvanced Hypertension Management.mp4\u003c\/li\u003e\n\u003cli\u003eBio-Identical Hormones and Testosterone Supplementation.mp4\u003c\/li\u003e\n\u003cli\u003eEvaluate Horrible Cholesterol, Lipoprotein A Prevalence, Impact, and Novel Therapeutics.mp4\u003c\/li\u003e\n\u003cli\u003eGenetic Testing for Familial Hypercholesterolemia When to Test, Whom to Test.mp4\u003c\/li\u003e\n\u003cli\u003eNew Concepts in Dyslipidemia Dispelling 10 Truths About Lipids.mp4\u003c\/li\u003e\n\u003cli\u003eNon-HDL Targets for Risk Reduction.mp4\u003c\/li\u003e\n\u003cli\u003eNonalcoholic Fatty Liver Disease and Its Contribution to CV Disease.mp4\u003c\/li\u003e\n\u003cli\u003eObesity and Diabetic Pharmacotherapy Are You Ready for GLP-1 Agonists.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion Q\u0026amp;A 1.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion Q\u0026amp;A 2.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion Q\u0026amp;A 3.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion Q\u0026amp;A 4.mp4\u003c\/li\u003e\n\u003cli\u003eSupplements in Primary and Secondary Prevention of ASCVD.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954372022370,"sku":"MED-AMB02092","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-Cardiovascular-Atherosclerosis-Prediction-Prevention-and-Management-2023.jpg?v=1779374825","url":"https:\/\/meducourse.com\/products\/scripps-cardiovascular-atherosclerosis-prediction-prevention-and-management-2023","provider":"Meducourse","version":"1.0","type":"link"}